These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37209921)
1. Diagnostic utility of PRAME immunohistochemistry in PEComa family of tumors and morphologic mimics with emphasis on the gynecologic tract. Smithgall MC; Liu-Jarin X; Chen X; Singh K; Quddus MR; Cimic A Hum Pathol; 2023 Aug; 138():12-17. PubMed ID: 37209921 [TBL] [Abstract][Full Text] [Related]
2. PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa). Valencia-Guerrero A; Pinto A; Anderson WJ; Trevisan G; Nucci MR; Hirsch MS Int J Gynecol Pathol; 2020 Nov; 39(6):529-536. PubMed ID: 31851063 [TBL] [Abstract][Full Text] [Related]
3. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Vang R; Kempson RL Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764 [TBL] [Abstract][Full Text] [Related]
4. PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours. Gulavita P; Fletcher CDM; Hirsch MS Histopathology; 2018 Feb; 72(3):441-448. PubMed ID: 28837273 [TBL] [Abstract][Full Text] [Related]
5. [Perivascular epithelioid cell tumor of urinary system: a clinicopathologic analysis of 21 cases]. Wang GW; Wang Y; Chen YX; Li Q; Shen DH Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):443-7. PubMed ID: 22932453 [TBL] [Abstract][Full Text] [Related]
6. Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall. Van Winden VI; Wong DD; Wood BA; Filion P; Harvey NT Pathology; 2024 Feb; 56(1):47-51. PubMed ID: 37989630 [TBL] [Abstract][Full Text] [Related]
7. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Wangsiricharoen S; Ingram DR; Morey RR; Wani K; Lazar AJ; Wang WL Mod Pathol; 2024 Mar; 37(3):100426. PubMed ID: 38219952 [TBL] [Abstract][Full Text] [Related]
8. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Folpe AL; Mentzel T; Lehr HA; Fisher C; Balzer BL; Weiss SW Am J Surg Pathol; 2005 Dec; 29(12):1558-75. PubMed ID: 16327428 [TBL] [Abstract][Full Text] [Related]
9. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma. Ferenczi K; Lastra RR; Farkas T; Elenitsas R; Xu X; Roberts S; Brooks JS; Zhang PJ Int J Surg Pathol; 2012 Feb; 20(1):29-36. PubMed ID: 21903680 [TBL] [Abstract][Full Text] [Related]
10. [Uterine malignant perivascular epithelioid cell tumor (PEComa): Two case reports]. El Gani-Mesrar M; Bonneau C; Michenet P; Gourvennec JB; Tabareau-Delalande F Ann Pathol; 2021 Feb; 41(1):118-122. PubMed ID: 32646778 [TBL] [Abstract][Full Text] [Related]
11. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications. Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762 [TBL] [Abstract][Full Text] [Related]
12. Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions. Bennett JA; Ordulu Z; Pinto A; Wanjari P; Antonescu CR; Ritterhouse LL; Oliva E Mod Pathol; 2022 Apr; 35(4):515-523. PubMed ID: 34131293 [TBL] [Abstract][Full Text] [Related]
13. Performance of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry for metastatic melanoma in cytology specimens. Saad M; Cantley R; Hao W; Wang Z; Thomas D; Pantanowitz L; Jin X Diagn Cytopathol; 2024 Jul; 52(7):362-368. PubMed ID: 38558495 [TBL] [Abstract][Full Text] [Related]
14. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852 [TBL] [Abstract][Full Text] [Related]
15. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Grillini M; Ricci C; Pino V; Pedrini S; Fiorentino M; Corti B Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):14-18. PubMed ID: 34508017 [TBL] [Abstract][Full Text] [Related]
16. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus. Cao B; Huang Y BMC Womens Health; 2022 Dec; 22(1):523. PubMed ID: 36522714 [TBL] [Abstract][Full Text] [Related]
17. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors. Fadare O; Liang SX Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203 [TBL] [Abstract][Full Text] [Related]
18. A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors. Lee CH; Turbin DA; Sung YC; Espinosa I; Montgomery K; van de Rijn M; Gilks CB Mod Pathol; 2009 Dec; 22(12):1519-31. PubMed ID: 19734847 [TBL] [Abstract][Full Text] [Related]
19. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report. Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531 [TBL] [Abstract][Full Text] [Related]
20. Multifocal perivascular epithelioid cell tumor of the uterus: report of one case and literature review. Guo J; Zhou X; Li Y; Wu X; Yang R; Zhou L Int J Clin Exp Pathol; 2019; 12(11):4113-4118. PubMed ID: 31933807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]